against tuberculosis in neonates (priMe) is currently ongoing at nine trial sites in five Sub-Saharan African countries (NCT 04351685) with financial support from the European Investment Bank. Moreover, for a clinical study assessing therapy of bladder cancer with the vaccine has revealed highly promising data (NCT 02371447). Furthermore, Kaufmann is actively involved in public awareness of immunology and infectious diseases (EFIS – Day of Immunology). In his recent books written in German, he has answered questions on Covid-19 and vaccination in a detailed and comprehensible manner. He is past president and honorary member of the German Society of Immunology (DGfI), past president of the European Federation of Immunological Societies (EFIS), and past president of the International Union of Immunological Societies (IUIS). From 2010 to 2013 he was member of the board of the Global Alliance for Vaccines and Immunization (GAVI) as alternate representative of scientific and technical institutes. From 2009 to 2014 he was a member of the advisory board of Global Alliance for TB Drug Development (TB Alliance) , New York. From 2014 to 2018 he was member of the strategic advisory committee of the European and Developing Countries Clinical Trials Partnership (EDCTP) . Kaufmann was member of the board of directors from 2003 to 2019 and of the scientific advisory council from 1998 to 2017 of the Robert Koch Foundation, which annually awards the Robert Koch Prize and the Robert Koch Medal in gold. Since 2014 he is chairman of the board of trustees of the Schering Foundation. From 2013 to 2014 he was corresponding member of the board of trustees and since 2014 he is full member of the board of trustees for the Lindau Nobel Laureate meetings for the Lindau Nobel Laureate Meetings. Since 2018 he is member of the Governance Board of the TuBerculosis Vaccine Initiative (TBVI) . Kaufmann headed a team that developed a method of using defensins to combat anthrax. Other activities Schering Foundation (Schering Stiftung), Chairman of the Board (since 2014) Lindau Nobel Laureate Meetings, Corresponding Member (2013–2014), Full Member of the Board of Trustees (since 2014) World Health Summit, Member of the Council Berlin-Brandenburg Academy of Sciences :de:Berlin-Brandenburgische Akademie der Wissenschaften, Member German Academy of Sciences Leopoldina, Member American Academy of Microbiology, Member European Molecular Biology Organization (EMBO), Member Global Alliance for TB Drug Development (TB Alliance), Member of the Advisory Board (2009–2014) Lindau Nobel Laureate Meetings, Member of the Council